Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/47/a0/3f/47a03f03-b595-12fe-9dc3-136566910bd5/mza_9141666422414174576.jpg/600x600bb.jpg
Medical Industry Feature
ReachMD
32 episodes
3 days ago
Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.
Show more...
Science
Medicine
RSS
All content for Medical Industry Feature is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.
Show more...
Science
Medicine
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/47/a0/3f/47a03f03-b595-12fe-9dc3-136566910bd5/mza_9141666422414174576.jpg/600x600bb.jpg
Immune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
Medical Industry Feature
3 months ago
Immune Imprinting and Vaccines: Rethinking the First Exposure to Influenza

Immune imprinting refers to how the immune system's first encounter with a virus, such as influenza, leaves a lasting imprint that shapes future immune responses.1,2 However, influenza vaccines may affect this process—particularly when egg-based ones are used. Tune in to learn about the impact of immune imprinting, the role that vaccines play in this process, and how switching to non-egg-based vaccines could help redirect immune responses and possibly create more effective defenses in people of all ages.3,4

References:

  1. King SM, Bryan SP, Hilchey SP, Wang J, Zand MS. First impressions matter: Immune imprinting and antibody cross-reactivity in influenza and SARS-CoV-2. Pathogens. 2023;12(2):169. doi:10.3390/pathogens12020169
  2. Zhang A, Stacey HD, Mullarkey CE, Miller MS. Original antigenic sin: How first exposure shapes lifelong anti-influenza virus immune responses. J Immunol. 2019;202(2):335–340. doi:10.4049/jimmunol.1801149
  3. Rockman S, Laurie K, Ong C, et al. Cell-based manufacturing technology increases antigenic match of influenza vaccine and results in improved effectiveness. Vaccines (Basel). 2022;11(1):52. doi:10.3390/vaccines11010052
  4. Liu F, Gross FL, Jefferson SN, et al. Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination. J Clin Invest. 2021;131(8):e146138. doi:10.1172/JCI146138

USA-CRP-24-0038 July 2025

Medical Industry Feature
Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.